- Report
- May 2026
- 500 Pages
Global
From €4459EUR$4,995USD£3,816GBP
- Report
- December 2025
- 343 Pages
Global
From €4284EUR$4,799USD£3,667GBP
- Report
- February 2026
- 299 Pages
Global
From €2232EUR$2,500USD£1,910GBP
- Report
- August 2026
- 196 Pages
Global
From €3165EUR$3,545USD£2,709GBP
€3517EUR$3,939USD£3,010GBP
- Report
- February 2026
- 141 Pages
Global
From €2677EUR$2,999USD£2,291GBP
€3570EUR$3,999USD£3,055GBP
- Report
- August 2026
- 480 Pages
Global
From €5223EUR$5,850USD£4,470GBP
- Report
- August 2026
- 320 Pages
Global
From €5223EUR$5,850USD£4,470GBP
- Report
- August 2026
- 187 Pages
Global
From €3165EUR$3,545USD£2,709GBP
€3517EUR$3,939USD£3,010GBP
- Report
- August 2026
- 180 Pages
Global
From €3165EUR$3,545USD£2,709GBP
€3517EUR$3,939USD£3,010GBP
- Report
- January 2026
- 184 Pages
Global
From €3165EUR$3,545USD£2,709GBP
€3517EUR$3,939USD£3,010GBP
- Report
- February 2026
- 250 Pages
Global
From €4008EUR$4,490USD£3,431GBP
- Report
- August 2026
- 180 Pages
Global
From €4241EUR$4,750USD£3,629GBP
- Report
- August 2026
- 130 Pages
Global
From €4241EUR$4,750USD£3,629GBP
- Report
- July 2026
- 125 Pages
Global
From €4241EUR$4,750USD£3,629GBP
- Report
- April 2026
- 145 Pages
Global
From €3500EUR$4,200USD£3,100GBP
- Training
- September 2027
- 2 Days
Global
€1571EUR$1,821USD£1,299GBP
€1813EUR$2,102USD£1,499GBP
- Training
- March 2027
- 2 Days
Global
€1571EUR$1,821USD£1,299GBP
€1813EUR$2,102USD£1,499GBP
- Training
- September 2026
- 2 Days
Global
€1813EUR$2,102USD£1,499GBP
€785EUR$910USD£649GBP
€906EUR$1,050USD£749GBP
€785EUR$910USD£649GBP
€906EUR$1,050USD£749GBP

Advanced Therapy Medicinal Products (ATMPs) are a class of pharmaceuticals that are used to treat serious or life-threatening diseases and conditions. They are based on gene therapy, somatic cell therapy, and tissue engineering, and are designed to modify or replace a patient's cells or tissues. ATMPs are highly complex and require specialized manufacturing processes, and are subject to stringent regulatory requirements.
ATMPs are used to treat a wide range of diseases, including cancer, genetic disorders, and degenerative diseases. They are also used to treat conditions such as organ failure, autoimmune diseases, and cardiovascular diseases. ATMPs are often used in combination with other treatments, such as chemotherapy or radiation therapy.
Some companies in the ATMP market include Novartis, Gilead Sciences, Celgene, and Regeneron Pharmaceuticals. Show Less Read more